Effect of dexfenfluramine on the transcriptional activation of CRF and its type 1 receptor within the paraventricular nucleus of the rat hypothalamus

被引:36
作者
Laflamme, N
Bovetto, S
Richard, D
Rivest, S
机构
[1] CHU LAVAL, CTR RECH, MOLEC ENDOCRINOL LAB, QUEBEC CITY, PQ G1V 4G2, CANADA
[2] UNIV LAVAL, DEPT PHYSIOL, QUEBEC CITY, PQ G1V 4G2, CANADA
关键词
corticotropin-releasing factor; c-fos; dexfenfluramine; hypothalamic-pituitary-adrenal axis immediate early genes; insitu hybridization histochemistry; immunocytochemistry intronic probe technology; 5-HT;
D O I
10.1111/j.1476-5381.1996.tb16692.x
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
1 The present study investigated the effect of intraperitoneal (i.p.) administration of the indirect 5-hydroxytryptamine (5-HT) receptor agonist, dexfenfluramine, on the transcriptional activity of corticotropin-releasing factor (CRF) and its type 1 receptor in the brains of conscious male Sprague-Dawley rats via in situ hybridization histochemistry (ISHH) using both intronic and exonic probe technology. 2 The immediate early gene (IEG) c-fos mRNA was also used as index of cellular activity, whereas localization between CRF-immunoreactive (ir) perikarya and the IEG was accomplished to determine the site of CRF neuronal activation in the brain of dexfenfluramine-treated rats. 3 Thirty minutes, 1, 3, and 6 h after a single injection of either dexfenfluramine (10 mg kg(-1)) or the vehicle solution, adult male rats (230-260 g) were deeply anaesthetized and rapidly perfused with a 4% paraformaldehyde-borax solution (PF). The brains were removed from the skull, postfixed, and placed in a solution of 4% PF-10% sucrose overnight al 4 degrees C. Frozen brains were mounted on a microtome and cut from the olfactory bulb to the medulla in 30-mu m coronal sections. 4 Dexfenfluramine induced a general neuronal activation as indicated by the strong signal of c-fos mRNA in several structures of the brain, including the parietal cortex, caudate putamen, circumventricular organs, medial preoptic area, bed nucleus of the stria terminalis, choroid plexus, choroidal fissure, supraoptic nucleus, paraventricular nucleus of the hypothalamus (PVN), paraventricular nucleus of the thalamus, central nucleus of the amygdala, dorsomedial nucleus of the hypothalamus, laterodorsal tegmental nucleus, locus coeruleus, and several subdivisions of the dorsal vagal complex. In most of these structures, the signal was maximal at 30 min, still strong and positive at 60 min, largely decreased at 3 h, and had completely disappeared 6 h after injection. 5 In the parvocellular division of the PVN, the large majority of CRF-ir perikarya displayed a positive signal for the mRNA encoding c-fos, indicating a profound CRFergic activation within this neuroendocrine nucleus after dexfenfluramine administration. 6 Colocalization between CRF-ir neurones and c-fos positive cells was not detected in any other regions. This selective activation of PVN CRF neurones was also confirmed by the presence of CRF primary transcript; 30 min after i.p. injection of the indirect 5-HT agonist, a positive signal for CRF hnRNA was observed, specifically in the parvocellular PVN. 7 Transcription of the gene encoding the type 1 receptor for CRF was highly stimulated in the PVN following 5-HT activation. Although this hypothalamic nucleus exhibited a barely detectable signal under basal conditions, dexfenfluramine induced a strong signal of CRF(1) receptor mRNA in the parvocellular PVN. Interestingly, CRF-ir neurones displayed a positive signal for the mRNA encoding the CRF(1) receptor, 3 and 6 h after systemic treatment with dexfenfluramine. 8 These results indicate that although dexfenfluramine can generate a wide neuronal activation throughout the brain, this 5-HT agonist triggers the activity of CRF neurones selectively in the parvocellular division of the PVN, a mechanism possibly related to the activity of hypothalamic-pituitary-adrenal axis. Induction of CRF(1) receptor mRNA in CRF cells of the PVN indicates that neuroendocrine CRF neurones can be targeted by CNS CRF under 5-HT stimulation.
引用
收藏
页码:1021 / 1034
页数:14
相关论文
共 82 条
[1]   EVIDENCE FOR CENTRAL AND PERIPHERAL SEROTONERGIC CONTROL OF CORTICOSTERONE SECRETION IN THE CONSCIOUS RAT [J].
ALPER, RH .
NEUROENDOCRINOLOGY, 1990, 51 (03) :255-260
[2]   ROLE FOR BRAIN CORTICOTROPIN-RELEASING FACTOR IN THE WEIGHT-REDUCING EFFECTS OF CHRONIC FENFLURAMINE TREATMENT IN RATS [J].
APPEL, NM ;
OWENS, MJ ;
CULP, S ;
ZACZEK, R ;
CONTRERA, JF ;
BISSETTE, G ;
NEMEROFF, CB ;
DESOUZA, EB .
ENDOCRINOLOGY, 1991, 128 (06) :3237-3246
[3]   TRACING SPECIFIC TRANSMITTER PATHWAYS IN THE RAT CNS - COMBINATION OF [H-3] SEROTONIN RETROGRADE LABELING WITH IMMUNOCYTOCHEMICAL DETECTION OF ENDOGENOUS TRANSMITTERS [J].
ARANEDA, S ;
MAGOUL, R ;
CALAS, A .
JOURNAL OF NEUROSCIENCE METHODS, 1989, 30 (03) :211-218
[4]   TRANSSYNAPTIC CONTROL OF GENE-EXPRESSION [J].
ARMSTRONG, RC ;
MONTMINY, MR .
ANNUAL REVIEW OF NEUROSCIENCE, 1993, 16 :17-29
[5]   PHYSIOLOGY OF NEURAL PATHWAYS AFFECTING CRH SECRETION [J].
ASSENMACHER, I ;
SZAFARCZYK, A ;
ALONSO, G ;
IXART, G ;
BARBANEL, G .
ANNALS OF THE NEW YORK ACADEMY OF SCIENCES, 1987, 512 :149-161
[6]   SEROTONIN AGONISTS CAUSE PARALLEL ACTIVATION OF THE SYMPATHOADRENOMEDULLARY SYSTEM AND THE HYPOTHALAMO-PITUITARY-ADRENOCORTICAL AXIS IN CONSCIOUS RATS [J].
BAGDY, G ;
CALOGERO, AE ;
MURPHY, DL ;
SZEMEREDI, K .
ENDOCRINOLOGY, 1989, 125 (05) :2664-2669
[7]  
BEAULIEU J, 1994, SOC NEUR ABSTR, V20, P45
[8]  
BEITZ AJ, 1982, J NEUROSCI, V2, P829
[9]   COMPARISON OF THE INFLUENCE OF ROSTRAL AND CAUDAL RAPHE NEURONS ON THE ADRENAL SECRETION OF CATECHOLAMINES AND ON THE RELEASE OF ADRENOCORTICOTROPIN IN THE CAT [J].
BEREITER, DA ;
GANN, DS .
PAIN, 1990, 42 (01) :81-91
[10]   ORIGINS OF SEROTONERGIC PROJECTIONS TO THE SPINAL-CORD IN RAT - AN IMMUNOCYTOCHEMICAL-RETROGRADE TRANSPORT STUDY [J].
BOWKER, RM ;
WESTLUND, KN ;
COULTER, JD .
BRAIN RESEARCH, 1981, 226 (1-2) :187-199